hydroxychloroquine has been researched along with Encephalopathy, Traumatic in 1 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hydroxychloroquine (HCQ) has already been used clinically for decades, and it is still widely used to treat various autoimmune diseases." | 3.11 | Hydroxychloroquine attenuates neuroinflammation following traumatic brain injury by regulating the TLR4/NF-κB signaling pathway. ( Chen, K; Chen, X; Fang, Y; Guo, K; Hu, J; Liang, F; Lin, L; Peng, W; Tan, X; Wang, X; Wang, Z; Xiong, Y, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, J | 1 |
| Wang, X | 1 |
| Chen, X | 1 |
| Fang, Y | 1 |
| Chen, K | 1 |
| Peng, W | 1 |
| Wang, Z | 1 |
| Guo, K | 1 |
| Tan, X | 1 |
| Liang, F | 1 |
| Lin, L | 1 |
| Xiong, Y | 1 |
1 trial available for hydroxychloroquine and Encephalopathy, Traumatic
| Article | Year |
|---|---|
Hydroxychloroquine attenuates neuroinflammation following traumatic brain injury by regulating the TLR4/NF-κB signaling pathway.
Topics: Animals; Brain Injuries, Traumatic; Disease Models, Animal; Hydroxychloroquine; Mice; Mice, Inbred C | 2022 |